How do your mood patterns compare to the population?

The average delay between symptom onset and correct bipolar diagnosis is 5-10 years. Most people with bipolar disorder first seek help during a depressive episode, not a manic or hypomanic episode, because depression is experienced as distressing while hypomania often feels good. Without a clear history of mania or hypomania, clinicians may diagnose unipolar depression. Approximately 40-70% of bipolar patients are initially misdiagnosed.

Yes. Bipolar disorder is one of the most treatable serious psychiatric conditions when correctly identified. First-line treatments include mood stabilisers (lithium, valproate, lamotrigine), atypical antipsychotics, and psychotherapy. With appropriate treatment, most people with bipolar disorder achieve significant symptom control and lead full, productive lives. The biggest barrier to effective treatment is the diagnostic delay, which screening tools like the MDQ aim to reduce.

Bipolar I disorder involves at least one full manic episode lasting at least 7 days (or requiring hospitalisation). Bipolar II involves at least one hypomanic episode (similar features but lasting at least 4 days, less severe) plus at least one major depressive episode. Bipolar II is not a milder form of Bipolar I; it involves more time in depression and carries its own significant burden. The MDQ screens for both.

No. No online quiz can diagnose bipolar disorder. The MDQ is a validated screening tool designed to identify people who may benefit from a full diagnostic evaluation. Diagnosis requires a comprehensive assessment by a psychiatrist or psychologist, including detailed history of mood episodes, their duration and severity, family history, and ruling out other conditions. The MDQ was developed to reduce the diagnostic delay that characterises bipolar disorder, not to replace clinical assessment. A positive screen is a reason to seek evaluation, not a diagnosis.

Normal mood variability involves reactions to life events that are proportional and temporary. Bipolar disorder involves discrete episodes of mania or hypomania with specific features: markedly reduced need for sleep, grandiosity, pressured speech, racing thoughts, increased goal-directed activity, and risky behaviour. These episodes last at least several days (4 or more days for hypomania, 7 or more for mania) and represent a clear change from the person's baseline functioning. The key distinction is that bipolar mood episodes are qualitatively different from normal mood fluctuations, not just more intense versions of everyday highs and lows.

Bipolar spectrum disorders affect approximately 2.8% of US adults, according to the National Institute of Mental Health. This includes Bipolar I (around 1.0%), Bipolar II (around 1.1%), and subthreshold bipolar conditions. Prevalence is roughly equal between men and women, though women are more likely to be diagnosed with Bipolar II and men with Bipolar I. The median age of onset is 25, though symptoms can begin in adolescence. Globally, bipolar spectrum prevalence is approximately 2.4% (Merikangas et al. 2011).

A positive screen means you endorsed 7 or more of the 13 symptom items, reported that several occurred during the same period, and rated them as causing moderate or serious problems. This pattern is associated with bipolar spectrum disorders in clinical settings. However, the MDQ has a specificity of 90% in clinical settings, meaning some positive screens are false positives. Other conditions, including ADHD, borderline personality disorder, and substance use disorders, can produce similar symptom patterns. A positive screen warrants professional evaluation, but it does not confirm bipolar disorder.

Yes. Many conditions share symptoms with bipolar disorder. ADHD involves distractibility, impulsivity, and restlessness. Borderline personality disorder involves emotional instability and impulsive behaviour. Substance use can produce manic-like episodes. Thyroid disorders can cause mood cycling. Unipolar depression with irritability can mimic mixed episodes. PTSD and complex trauma can produce mood instability. This is precisely why clinical assessment is essential: a trained professional considers the full picture, including timing of symptoms, their episodic nature, family history, and other medical conditions.

The MDQ has known limitations. Its sensitivity in general population samples is only 28%, meaning it misses approximately 72% of people with bipolar disorder when used outside clinical settings. Sensitivity is higher in psychiatric outpatient settings (73%). The MDQ was validated primarily in adult samples and may perform differently in adolescents or older adults. Women with Bipolar II, whose hypomanic episodes tend to be less dramatic, may be less likely to endorse the MDQ items at threshold levels. A negative screen does not rule out bipolar disorder.